C
Dr. Reddy's Laboratories Limited
RDY
$12.70
-$0.21-1.63%
C
Hold
1/22/2025Downgrade
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C+ from B- on 1/22/2025 due to a decline in the volatility index and total return index.
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C+ from B- on 1/22/2025 due to a decline in the volatility index and total return index.
B
Buy
1/7/2025Upgraded
Dr. Reddy's Laboratories Limited (RDY) was upgraded to B- from C+ on 1/7/2025 due to an increase in the volatility index and total return index.
Dr. Reddy's Laboratories Limited (RDY) was upgraded to B- from C+ on 1/7/2025 due to an increase in the volatility index and total return index.
C
Hold
12/10/2024Downgrade
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C+ from B- on 12/10/2024 due to a major decline in the total return index, volatility index and solvency index. Debt to equity increased from 0.1 to 0.15, and the quick ratio declined from 1.66 to 1.17.
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C+ from B- on 12/10/2024 due to a major decline in the total return index, volatility index and solvency index. Debt to equity increased from 0.1 to 0.15, and the quick ratio declined from 1.66 to 1.17.
B
Buy
10/28/2024Downgrade
Dr. Reddy's Laboratories Limited (RDY) was downgraded to B- from B on 10/28/2024 due to a decline in the total return index.
Dr. Reddy's Laboratories Limited (RDY) was downgraded to B- from B on 10/28/2024 due to a decline in the total return index.
B
Buy
10/11/2024Upgraded
Dr. Reddy's Laboratories Limited (RDY) was upgraded to B from B- on 10/11/2024 due to a substantial increase in the total return index and volatility index.
Dr. Reddy's Laboratories Limited (RDY) was upgraded to B from B- on 10/11/2024 due to a substantial increase in the total return index and volatility index.
B
Buy
6/14/2024Upgraded
Dr. Reddy's Laboratories Limited (RDY) was upgraded to B- from C+ on 6/14/2024 due to an increase in the dividend index, efficiency index and solvency index. Debt to equity declined from 0.07 to 0.06, total capital increased 4.37% from $3.46B to $3.61B, and the quick ratio increased from 1.65 to 1.71.
Dr. Reddy's Laboratories Limited (RDY) was upgraded to B- from C+ on 6/14/2024 due to an increase in the dividend index, efficiency index and solvency index. Debt to equity declined from 0.07 to 0.06, total capital increased 4.37% from $3.46B to $3.61B, and the quick ratio increased from 1.65 to 1.71.
C
Hold
5/29/2024Downgrade
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C+ from B- on 5/29/2024 due to a decline in the total return index and volatility index.
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C+ from B- on 5/29/2024 due to a decline in the total return index and volatility index.
B
Buy
5/14/2024Downgrade
Dr. Reddy's Laboratories Limited (RDY) was downgraded to B- from B on 5/14/2024 due to a decline in the volatility index, total return index and growth index.
Dr. Reddy's Laboratories Limited (RDY) was downgraded to B- from B on 5/14/2024 due to a decline in the volatility index, total return index and growth index.
B
Buy
4/17/2024Upgraded
Dr. Reddy's Laboratories Limited (RDY) was upgraded to B from B- on 4/17/2024 due to a noticeable increase in the total return index, volatility index and solvency index. The quick ratio increased from 1.65 to 1.65.
Dr. Reddy's Laboratories Limited (RDY) was upgraded to B from B- on 4/17/2024 due to a noticeable increase in the total return index, volatility index and solvency index. The quick ratio increased from 1.65 to 1.65.
B
Buy
11/28/2023Upgraded
Dr. Reddy's Laboratories Limited (RDY) was upgraded to B- from C+ on 11/28/2023 due to an increase in the total return index.
Dr. Reddy's Laboratories Limited (RDY) was upgraded to B- from C+ on 11/28/2023 due to an increase in the total return index.
C
Hold
11/3/2023Downgrade
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C+ from B- on 11/3/2023 due to a decline in the total return index, efficiency index and growth index.
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C+ from B- on 11/3/2023 due to a decline in the total return index, efficiency index and growth index.
B
Buy
9/28/2023Upgraded
Dr. Reddy's Laboratories Limited (RDY) was upgraded to B- from C+ on 9/28/2023 due to an increase in the total return index, valuation index and volatility index.
Dr. Reddy's Laboratories Limited (RDY) was upgraded to B- from C+ on 9/28/2023 due to an increase in the total return index, valuation index and volatility index.
C
Hold
9/12/2023Downgrade
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C+ from B- on 9/12/2023 due to a decline in the total return index.
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C+ from B- on 9/12/2023 due to a decline in the total return index.
B
Buy
8/25/2023Upgraded
Dr. Reddy's Laboratories Limited (RDY) was upgraded to B- from C+ on 8/25/2023 due to an increase in the volatility index, total return index and growth index.
Dr. Reddy's Laboratories Limited (RDY) was upgraded to B- from C+ on 8/25/2023 due to an increase in the volatility index, total return index and growth index.
C
Hold
7/28/2023Downgrade
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C+ from B- on 7/28/2023 due to a decline in the dividend index and valuation index.
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C+ from B- on 7/28/2023 due to a decline in the dividend index and valuation index.
B
Buy
6/15/2023Upgraded
Dr. Reddy's Laboratories Limited (RDY) was upgraded to B- from C+ on 6/15/2023 due to an increase in the valuation index, dividend index and volatility index.
Dr. Reddy's Laboratories Limited (RDY) was upgraded to B- from C+ on 6/15/2023 due to an increase in the valuation index, dividend index and volatility index.
C
Hold
5/16/2023Downgrade
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C+ from B- on 5/16/2023 due to a decline in the volatility index.
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C+ from B- on 5/16/2023 due to a decline in the volatility index.
B
Buy
5/1/2023Upgraded
Dr. Reddy's Laboratories Limited (RDY) was upgraded to B- from C+ on 5/1/2023 due to a noticeable increase in the total return index.
Dr. Reddy's Laboratories Limited (RDY) was upgraded to B- from C+ on 5/1/2023 due to a noticeable increase in the total return index.
C
Hold
4/19/2023Upgraded
Dr. Reddy's Laboratories Limited (RDY) was upgraded to C+ from C on 4/19/2023 due to an increase in the volatility index and total return index.
Dr. Reddy's Laboratories Limited (RDY) was upgraded to C+ from C on 4/19/2023 due to an increase in the volatility index and total return index.
C
Hold
3/8/2023Downgrade
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C from C+ on 3/8/2023 due to a decline in the volatility index and total return index.
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C from C+ on 3/8/2023 due to a decline in the volatility index and total return index.
C
Hold
2/21/2023Upgraded
Dr. Reddy's Laboratories Limited (RDY) was upgraded to C+ from C on 2/21/2023 due to a noticeable increase in the growth index, volatility index and efficiency index. Operating cash flow increased 143.37% from $116.36M to $283.2M, net income increased 8.83% from $139.52M to $151.84M, and earnings per share increased from $0.8387 to $0.9125.
Dr. Reddy's Laboratories Limited (RDY) was upgraded to C+ from C on 2/21/2023 due to a noticeable increase in the growth index, volatility index and efficiency index. Operating cash flow increased 143.37% from $116.36M to $283.2M, net income increased 8.83% from $139.52M to $151.84M, and earnings per share increased from $0.8387 to $0.9125.
C
Hold
4/28/2022Downgrade
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C from C+ on 4/28/2022 due to a noticeable decline in the volatility index.
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C from C+ on 4/28/2022 due to a noticeable decline in the volatility index.
C
Hold
3/2/2022Downgrade
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C+ from B- on 3/2/2022 due to a decline in the total return index and volatility index.
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C+ from B- on 3/2/2022 due to a decline in the total return index and volatility index.
B
Buy
1/31/2022Upgraded
Dr. Reddy's Laboratories Limited (RDY) was upgraded to B- from C+ on 1/31/2022 due to a major increase in the valuation index, growth index and efficiency index. Operating cash flow increased 235.6% from $68.9M to $231.24M, and total capital increased 1.52% from $2.89B to $2.93B.
Dr. Reddy's Laboratories Limited (RDY) was upgraded to B- from C+ on 1/31/2022 due to a major increase in the valuation index, growth index and efficiency index. Operating cash flow increased 235.6% from $68.9M to $231.24M, and total capital increased 1.52% from $2.89B to $2.93B.
C
Hold
10/6/2021Downgrade
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C+ from B- on 10/6/2021 due to a large decline in the total return index, growth index and dividend index. Operating cash flow declined 130.23% from $154.56M to -$46.73M, and EBIT declined 12.4% from $101.77M to $89.15M.
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C+ from B- on 10/6/2021 due to a large decline in the total return index, growth index and dividend index. Operating cash flow declined 130.23% from $154.56M to -$46.73M, and EBIT declined 12.4% from $101.77M to $89.15M.
B
Buy
7/21/2021Downgrade
Dr. Reddy's Laboratories Limited (RDY) was downgraded to B- from B on 7/21/2021 due to a noticeable decline in the total return index.
Dr. Reddy's Laboratories Limited (RDY) was downgraded to B- from B on 7/21/2021 due to a noticeable decline in the total return index.
B
Buy
7/2/2021Upgraded
Dr. Reddy's Laboratories Limited (RDY) was upgraded to B from B- on 7/2/2021 due to a substantial increase in the total return index, growth index and dividend index. Earnings per share increased from $0.0161 to $0.2991, and operating cash flow increased 167.13% from $57.86M to $154.56M.
Dr. Reddy's Laboratories Limited (RDY) was upgraded to B from B- on 7/2/2021 due to a substantial increase in the total return index, growth index and dividend index. Earnings per share increased from $0.0161 to $0.2991, and operating cash flow increased 167.13% from $57.86M to $154.56M.
B
Buy
6/2/2021Upgraded
Dr. Reddy's Laboratories Limited (RDY) was upgraded to B- from C+ on 6/2/2021 due to an increase in the total return index, volatility index and growth index.
Dr. Reddy's Laboratories Limited (RDY) was upgraded to B- from C+ on 6/2/2021 due to an increase in the total return index, volatility index and growth index.
C
Hold
4/27/2021Downgrade
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C+ from B- on 4/27/2021 due to a decline in the valuation index, total return index and volatility index.
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C+ from B- on 4/27/2021 due to a decline in the valuation index, total return index and volatility index.
B
Buy
2/5/2021Upgraded
Dr. Reddy's Laboratories Limited (RDY) was upgraded to B- from C+ on 2/5/2021 due to a substantial increase in the valuation index, efficiency index and volatility index.
Dr. Reddy's Laboratories Limited (RDY) was upgraded to B- from C+ on 2/5/2021 due to a substantial increase in the valuation index, efficiency index and volatility index.
C
Hold
1/25/2021Downgrade
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C+ from B- on 1/25/2021 due to a major decline in the valuation index, total return index and efficiency index.
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C+ from B- on 1/25/2021 due to a major decline in the valuation index, total return index and efficiency index.
B
Buy
7/31/2020Downgrade
Dr. Reddy's Laboratories Limited (RDY) was downgraded to B- from B on 7/31/2020 due to a decline in the valuation index, growth index and dividend index. Earnings per share declined from $0.6348 to $0.4595, and total revenue declined 4.77% from $611.47M to $582.31M.
Dr. Reddy's Laboratories Limited (RDY) was downgraded to B- from B on 7/31/2020 due to a decline in the valuation index, growth index and dividend index. Earnings per share declined from $0.6348 to $0.4595, and total revenue declined 4.77% from $611.47M to $582.31M.
B
Buy
6/19/2020Upgraded
Dr. Reddy's Laboratories Limited (RDY) was upgraded to B from C on 6/19/2020 due to a significant increase in the growth index, valuation index and total return index. Earnings per share increased from -$0.4826 to $0.6348.
Dr. Reddy's Laboratories Limited (RDY) was upgraded to B from C on 6/19/2020 due to a significant increase in the growth index, valuation index and total return index. Earnings per share increased from -$0.4826 to $0.6348.
C
Hold
5/20/2020Downgrade
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C from C+ on 5/20/2020 due to a significant decline in the growth index and valuation index.
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C from C+ on 5/20/2020 due to a significant decline in the growth index and valuation index.
C
Hold
2/4/2020Downgrade
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C+ from B- on 2/4/2020 due to a substantial decline in the growth index, valuation index and efficiency index. Earnings per share declined from $0.9352 to -$0.4826, net income declined 151.54% from $155.22M to -$79.99M, and EBIT declined 33.65% from $154.2M to $102.31M.
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C+ from B- on 2/4/2020 due to a substantial decline in the growth index, valuation index and efficiency index. Earnings per share declined from $0.9352 to -$0.4826, net income declined 151.54% from $155.22M to -$79.99M, and EBIT declined 33.65% from $154.2M to $102.31M.
B
Buy
1/9/2020Upgraded
Dr. Reddy's Laboratories Limited (RDY) was upgraded to B- from C+ on 1/9/2020 due to an increase in the volatility index, total return index and growth index.
Dr. Reddy's Laboratories Limited (RDY) was upgraded to B- from C+ on 1/9/2020 due to an increase in the volatility index, total return index and growth index.
C
Hold
11/25/2019Upgraded
Dr. Reddy's Laboratories Limited (RDY) was upgraded to C+ from C on 11/25/2019 due to a significant increase in the growth index, total return index and solvency index. EBIT increased 139.29% from $64.44M to $154.2M, earnings per share increased from $0.5738 to $0.9352, and total revenue increased 23.43% from $552.61M to $682.11M.
Dr. Reddy's Laboratories Limited (RDY) was upgraded to C+ from C on 11/25/2019 due to a significant increase in the growth index, total return index and solvency index. EBIT increased 139.29% from $64.44M to $154.2M, earnings per share increased from $0.5738 to $0.9352, and total revenue increased 23.43% from $552.61M to $682.11M.
C
Hold
12/14/2018Upgraded
Dr. Reddy's Laboratories Limited (RDY) was upgraded to C from C- on 12/14/2018 due to an increase in the volatility index, efficiency index and total return index.
Dr. Reddy's Laboratories Limited (RDY) was upgraded to C from C- on 12/14/2018 due to an increase in the volatility index, efficiency index and total return index.
C
Hold
10/30/2018Upgraded
Dr. Reddy's Laboratories Limited (RDY) was upgraded to C- from D+ on 10/30/2018 due to a noticeable increase in the valuation index, growth index and total return index. Earnings per share increased from $0.4098 to $0.4326.
Dr. Reddy's Laboratories Limited (RDY) was upgraded to C- from D+ on 10/30/2018 due to a noticeable increase in the valuation index, growth index and total return index. Earnings per share increased from $0.4098 to $0.4326.
D
Sell
4/20/2018Downgrade
Dr. Reddy's Laboratories Limited (RDY) was downgraded to D+ from C- on 4/20/2018 due to a decline in the total return index, efficiency index and valuation index.
Dr. Reddy's Laboratories Limited (RDY) was downgraded to D+ from C- on 4/20/2018 due to a decline in the total return index, efficiency index and valuation index.
C
Hold
12/15/2017Upgraded
Dr. Reddy's Laboratories Limited (RDY) was upgraded to C- from D+ on 12/15/2017 due to an increase in the efficiency index, valuation index and total return index.
Dr. Reddy's Laboratories Limited (RDY) was upgraded to C- from D+ on 12/15/2017 due to an increase in the efficiency index, valuation index and total return index.
D
Sell
11/2/2017Upgraded
Dr. Reddy's Laboratories Limited (RDY) was upgraded to D+ from D on 11/2/2017 due to a significant increase in the growth index and valuation index. EBIT increased 735.74% from $7.09M to $59.24M, earnings per share increased from $0.0552 to $0.2668, and total revenue increased 7.26% from $514.29M to $551.6M.
Dr. Reddy's Laboratories Limited (RDY) was upgraded to D+ from D on 11/2/2017 due to a significant increase in the growth index and valuation index. EBIT increased 735.74% from $7.09M to $59.24M, earnings per share increased from $0.0552 to $0.2668, and total revenue increased 7.26% from $514.29M to $551.6M.
D
Sell
8/11/2017Downgrade
Dr. Reddy's Laboratories Limited (RDY) was downgraded to D from D+ on 8/11/2017 due to a decline in the growth index, dividend index and solvency index. Operating cash flow declined 124.11% from $127.31M to -$30.69M, EBIT declined 85.49% from $48.86M to $7.09M, and earnings per share declined from $0.2816 to $0.0552.
Dr. Reddy's Laboratories Limited (RDY) was downgraded to D from D+ on 8/11/2017 due to a decline in the growth index, dividend index and solvency index. Operating cash flow declined 124.11% from $127.31M to -$30.69M, EBIT declined 85.49% from $48.86M to $7.09M, and earnings per share declined from $0.2816 to $0.0552.
D
Sell
8/3/2017Downgrade
Dr. Reddy's Laboratories Limited (RDY) was downgraded to D+ from C- on 8/3/2017 due to a decline in the volatility index.
Dr. Reddy's Laboratories Limited (RDY) was downgraded to D+ from C- on 8/3/2017 due to a decline in the volatility index.
C
Hold
7/19/2017Upgraded
Dr. Reddy's Laboratories Limited (RDY) was upgraded to C- from D+ on 7/19/2017 due to an increase in the valuation index, dividend index and volatility index.
Dr. Reddy's Laboratories Limited (RDY) was upgraded to C- from D+ on 7/19/2017 due to an increase in the valuation index, dividend index and volatility index.
D
Sell
5/22/2017Downgrade
Dr. Reddy's Laboratories Limited (RDY) was downgraded to D+ from C- on 5/22/2017 due to a decline in the total return index, volatility index and growth index.
Dr. Reddy's Laboratories Limited (RDY) was downgraded to D+ from C- on 5/22/2017 due to a decline in the total return index, volatility index and growth index.
C
Hold
2/10/2017Downgrade
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C- from C on 2/10/2017 due to a decline in the volatility index, valuation index and solvency index. The quick ratio declined from 0.67 to 0.66.
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C- from C on 2/10/2017 due to a decline in the volatility index, valuation index and solvency index. The quick ratio declined from 0.67 to 0.66.
C
Hold
1/26/2017Upgraded
Dr. Reddy's Laboratories Limited (RDY) was upgraded to C from C- on 1/26/2017 due to an increase in the volatility index and valuation index.
Dr. Reddy's Laboratories Limited (RDY) was upgraded to C from C- on 1/26/2017 due to an increase in the volatility index and valuation index.
C
Hold
1/11/2017Downgrade
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C- from C on 1/11/2017 due to a major decline in the valuation index, solvency index and total return index. Debt to equity increased from 0.33 to 0.52, and the quick ratio declined from 0.93 to 0.67.
Dr. Reddy's Laboratories Limited (RDY) was downgraded to C- from C on 1/11/2017 due to a major decline in the valuation index, solvency index and total return index. Debt to equity increased from 0.33 to 0.52, and the quick ratio declined from 0.93 to 0.67.
C
Hold
7/1/2016Upgraded
Dr. Reddy's Laboratories Ltd. (RDY) was upgraded to C from D on 7/1/2016 due to a significant increase in the efficiency index, solvency index and growth index.
Dr. Reddy's Laboratories Ltd. (RDY) was upgraded to C from D on 7/1/2016 due to a significant increase in the efficiency index, solvency index and growth index.
D
Sell
6/24/2016Downgrade
Dr. Reddy's Laboratories Ltd. (RDY) was downgraded to D from C+ on 6/24/2016 due to a significant decline in the efficiency index, solvency index and growth index.
Dr. Reddy's Laboratories Ltd. (RDY) was downgraded to D from C+ on 6/24/2016 due to a significant decline in the efficiency index, solvency index and growth index.
C
Hold
4/8/2016Upgraded
Dr. Reddy's Laboratories Ltd. (RDY) was upgraded to C+ from C on 4/8/2016 due to an increase in the valuation index, volatility index and total return index.
Dr. Reddy's Laboratories Ltd. (RDY) was upgraded to C+ from C on 4/8/2016 due to an increase in the valuation index, volatility index and total return index.
C
Hold
3/11/2016Downgrade
Dr. Reddy's Laboratories Ltd. (RDY) was downgraded to C from B- on 3/11/2016 due to a noticeable decline in the volatility index, growth index and total return index. Earnings per share declined from $0.6497 to $0.5139, EBIT declined 15.41% from $142.45M to $120.5M, and total revenue declined 1.94% from $614.1M to $602.18M.
Dr. Reddy's Laboratories Ltd. (RDY) was downgraded to C from B- on 3/11/2016 due to a noticeable decline in the volatility index, growth index and total return index. Earnings per share declined from $0.6497 to $0.5139, EBIT declined 15.41% from $142.45M to $120.5M, and total revenue declined 1.94% from $614.1M to $602.18M.
B
Buy
1/20/2016Downgrade
Dr. Reddy's Laboratories Ltd. (RDY) was downgraded to B- from B on 1/20/2016 due to a large decline in the volatility index and total return index.
Dr. Reddy's Laboratories Ltd. (RDY) was downgraded to B- from B on 1/20/2016 due to a large decline in the volatility index and total return index.
B
Buy
12/17/2015Downgrade
Dr. Reddy's Laboratories Ltd. (RDY) was downgraded to B from B+ on 12/17/2015 due to a noticeable decline in the volatility index.
Dr. Reddy's Laboratories Ltd. (RDY) was downgraded to B from B+ on 12/17/2015 due to a noticeable decline in the volatility index.
B
Buy
12/14/2015Downgrade
Dr. Reddy's Laboratories Ltd. (RDY) was downgraded to B+ from A- on 12/14/2015 due to a noticeable decline in the volatility index.
Dr. Reddy's Laboratories Ltd. (RDY) was downgraded to B+ from A- on 12/14/2015 due to a noticeable decline in the volatility index.
A
Buy
12/7/2015Downgrade
Dr. Reddy's Laboratories Ltd. (RDY) was downgraded to A- from A on 12/7/2015 due to a large decline in the total return index and volatility index.
Dr. Reddy's Laboratories Ltd. (RDY) was downgraded to A- from A on 12/7/2015 due to a large decline in the total return index and volatility index.
A
Buy
11/20/2015Upgraded
Dr. Reddy's Laboratories Ltd. (RDY) was upgraded to A from A- on 11/20/2015 due to a noticeable increase in the growth index, valuation index and efficiency index. Operating cash flow increased 29.18% from $135.67M to $175.26M, EBIT increased 16.8% from $121.96M to $142.45M, and earnings per share increased from $0.5766 to $0.6497.
Dr. Reddy's Laboratories Ltd. (RDY) was upgraded to A from A- on 11/20/2015 due to a noticeable increase in the growth index, valuation index and efficiency index. Operating cash flow increased 29.18% from $135.67M to $175.26M, EBIT increased 16.8% from $121.96M to $142.45M, and earnings per share increased from $0.5766 to $0.6497.
A
Buy
8/28/2015Downgrade
Dr. Reddy's Laboratories Ltd. (RDY) was downgraded to A- from A on 8/28/2015 due to a decline in the dividend index and solvency index. The quick ratio declined from 1.33 to 1.2.
Dr. Reddy's Laboratories Ltd. (RDY) was downgraded to A- from A on 8/28/2015 due to a decline in the dividend index and solvency index. The quick ratio declined from 1.33 to 1.2.
A
Buy
8/24/2015Upgraded
Dr. Reddy's Laboratories Ltd. (RDY) was upgraded to A from A- on 8/24/2015 due to an increase in the valuation index and total return index.
Dr. Reddy's Laboratories Ltd. (RDY) was upgraded to A from A- on 8/24/2015 due to an increase in the valuation index and total return index.
A
Buy
8/20/2015Upgraded
Dr. Reddy's Laboratories Ltd. (RDY) was upgraded to A- from B+ on 8/20/2015 due to a large increase in the total return index.
Dr. Reddy's Laboratories Ltd. (RDY) was upgraded to A- from B+ on 8/20/2015 due to a large increase in the total return index.
B
Buy
8/5/2015Downgrade
Dr. Reddy's Laboratories Ltd. (RDY) was downgraded to B+ from A- on 8/5/2015 due to a decline in the valuation index and dividend index.
Dr. Reddy's Laboratories Ltd. (RDY) was downgraded to B+ from A- on 8/5/2015 due to a decline in the valuation index and dividend index.
A
Buy
6/19/2015Upgraded
Dr. Reddy's Laboratories Ltd. (RDY) was upgraded to A- from B+ on 6/19/2015 due to an increase in the total return index, dividend index and solvency index. The quick ratio increased from 1.19 to 1.33.
Dr. Reddy's Laboratories Ltd. (RDY) was upgraded to A- from B+ on 6/19/2015 due to an increase in the total return index, dividend index and solvency index. The quick ratio increased from 1.19 to 1.33.
B
Buy
2/11/2015Downgrade
Dr. Reddy's Laboratories Ltd. (RDY) was downgraded to B+ from A- on 2/11/2015 due to a decline in the growth index and valuation index. Operating cash flow declined 3.55% from $76.22M to $73.51M, and EBIT declined 2.07% from $108.94M to $106.68M.
Dr. Reddy's Laboratories Ltd. (RDY) was downgraded to B+ from A- on 2/11/2015 due to a decline in the growth index and valuation index. Operating cash flow declined 3.55% from $76.22M to $73.51M, and EBIT declined 2.07% from $108.94M to $106.68M.
A
Buy
9/16/2014Upgraded
Dr. Reddy's Laboratories Ltd. (RDY) was upgraded to A- from B+ on 9/16/2014 due to an increase in the volatility index and total return index.
Dr. Reddy's Laboratories Ltd. (RDY) was upgraded to A- from B+ on 9/16/2014 due to an increase in the volatility index and total return index.
B
Buy
9/8/2014Upgraded
Dr. Reddy's Laboratories Ltd. (RDY) was upgraded to B+ from B on 9/8/2014 due to an increase in the volatility index and total return index.
Dr. Reddy's Laboratories Ltd. (RDY) was upgraded to B+ from B on 9/8/2014 due to an increase in the volatility index and total return index.
B
Buy
8/21/2014Downgrade
Dr. Reddy's Laboratories Ltd. (RDY) was downgraded to B from B+ on 8/21/2014 due to a decline in the volatility index and dividend index.
Dr. Reddy's Laboratories Ltd. (RDY) was downgraded to B from B+ on 8/21/2014 due to a decline in the volatility index and dividend index.
B
Buy
8/1/2014Downgrade
Dr. Reddy's Laboratories Ltd. (RDY) was downgraded to B+ from A- on 8/1/2014 due to a decline in the volatility index, valuation index and dividend index.
Dr. Reddy's Laboratories Ltd. (RDY) was downgraded to B+ from A- on 8/1/2014 due to a decline in the volatility index, valuation index and dividend index.
A
Buy
6/30/2014Upgraded
Dr. Reddy's Laboratories Ltd. (RDY) was upgraded to A- from B on 6/30/2014 due to an increase in the volatility index, dividend index and solvency index. Debt to equity declined from 0.57 to 0.47, and the quick ratio increased from 1.16 to 1.3.
Dr. Reddy's Laboratories Ltd. (RDY) was upgraded to A- from B on 6/30/2014 due to an increase in the volatility index, dividend index and solvency index. Debt to equity declined from 0.57 to 0.47, and the quick ratio increased from 1.16 to 1.3.
B
Buy
6/20/2014Downgrade
Dr. Reddy's Laboratories Ltd. (RDY) was downgraded to B from B+ on 6/20/2014 due to a noticeable decline in the volatility index and valuation index.
Dr. Reddy's Laboratories Ltd. (RDY) was downgraded to B from B+ on 6/20/2014 due to a noticeable decline in the volatility index and valuation index.
B
Buy
6/5/2014Downgrade
Dr. Reddy's Laboratories Ltd. (RDY) was downgraded to B+ from A- on 6/5/2014 due to a decline in the total return index and volatility index.
Dr. Reddy's Laboratories Ltd. (RDY) was downgraded to B+ from A- on 6/5/2014 due to a decline in the total return index and volatility index.
NYSE
03/10/2025 4:00PM Eastern
Quotes delayed
